CA2617765A1 - Capteurs electrochimiques reversibles de polyions - Google Patents

Capteurs electrochimiques reversibles de polyions Download PDF

Info

Publication number: CA2617765A1
Authority: CA; Canada
Prior art keywords: membrane; polyion; electrode; sample solution; concentration
Prior art date: 2005-08-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002617765A

Other languages

English (en)

Inventor

Eric Bakker

Alexey Shvarev

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Auburn University

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-08-05

Filing date

2006-07-27

Publication date

2007-02-15

2006-07-27 Application filed by Individual filed Critical Individual

2006-07-27 Priority claimed from PCT/US2006/029634 external-priority patent/WO2007019097A2/fr

2007-02-15 Publication of CA2617765A1 publication Critical patent/CA2617765A1/fr

Status Abandoned legal-status Critical Current

Links

229920000831 ionic polymer Polymers 0.000 title claims abstract description 204
230000002441 reversible effect Effects 0.000 title claims abstract description 27
239000012528 membrane Substances 0.000 claims abstract description 247
229940048914 protamine Drugs 0.000 claims abstract description 131
102000007327 Protamines Human genes 0.000 claims abstract description 129
108010007568 Protamines Proteins 0.000 claims abstract description 129
230000000694 effects Effects 0.000 claims abstract description 50
102000004190 Enzymes Human genes 0.000 claims abstract description 32
108090000790 Enzymes Proteins 0.000 claims abstract description 32
239000008280 blood Substances 0.000 claims abstract description 26
210000004369 blood Anatomy 0.000 claims abstract description 26
239000002532 enzyme inhibitor Substances 0.000 claims abstract description 16
229940125532 enzyme inhibitor Drugs 0.000 claims abstract description 15
238000000354 decomposition reaction Methods 0.000 claims abstract description 10
238000003018 immunoassay Methods 0.000 claims abstract 2
239000012488 sample solution Substances 0.000 claims description 67
238000000034 method Methods 0.000 claims description 45
102000004142 Trypsin Human genes 0.000 claims description 31
108090000631 Trypsin Proteins 0.000 claims description 31
239000012588 trypsin Substances 0.000 claims description 29
239000003112 inhibitor Substances 0.000 claims description 16
235000010469 Glycine max Nutrition 0.000 claims description 9
244000068988 Glycine max Species 0.000 claims description 9
230000007423 decrease Effects 0.000 claims description 8
229910021607 Silver chloride Inorganic materials 0.000 claims description 5
HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 claims description 5
108010039627 Aprotinin Proteins 0.000 claims description 4
229960004405 aprotinin Drugs 0.000 claims description 4
ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 claims description 4
239000000137 peptide hydrolase inhibitor Substances 0.000 claims description 4
230000001419 dependent effect Effects 0.000 claims description 3
239000003550 marker Substances 0.000 claims 3
239000003792 electrolyte Substances 0.000 abstract description 57
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 abstract description 48
229920000669 heparin Polymers 0.000 abstract description 48
229960002897 heparin Drugs 0.000 abstract description 48
238000000605 extraction Methods 0.000 abstract description 25
238000005259 measurement Methods 0.000 abstract description 20
230000002269 spontaneous effect Effects 0.000 abstract description 10
238000004448 titration Methods 0.000 abstract description 10
238000005342 ion exchange Methods 0.000 abstract description 5
210000004379 membrane Anatomy 0.000 description 210
150000001768 cations Chemical class 0.000 description 50
230000004044 response Effects 0.000 description 47
150000001450 anions Chemical class 0.000 description 45
239000000243 solution Substances 0.000 description 35
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 34
239000000523 sample Substances 0.000 description 28
241000894007 species Species 0.000 description 28
150000002500 ions Chemical class 0.000 description 27
239000012071 phase Substances 0.000 description 23
239000004014 plasticizer Substances 0.000 description 17
239000011734 sodium Substances 0.000 description 17
239000011780 sodium chloride Substances 0.000 description 17
239000000758 substrate Substances 0.000 description 17
239000000463 material Substances 0.000 description 16
238000011088 calibration curve Methods 0.000 description 14
238000002474 experimental method Methods 0.000 description 14
229910052708 sodium Inorganic materials 0.000 description 13
-1 sodium cations Chemical class 0.000 description 13
229910001415 sodium ion Inorganic materials 0.000 description 13
238000006243 chemical reaction Methods 0.000 description 12
238000009792 diffusion process Methods 0.000 description 12
230000004907 flux Effects 0.000 description 12
239000012088 reference solution Substances 0.000 description 12
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 11
230000008859 change Effects 0.000 description 11
238000001514 detection method Methods 0.000 description 11
150000001875 compounds Chemical class 0.000 description 9
CXVOIIMJZFREMM-UHFFFAOYSA-N 1-(2-nitrophenoxy)octane Chemical group CCCCCCCCOC1=CC=CC=C1[N+]([O-])=O CXVOIIMJZFREMM-UHFFFAOYSA-N 0.000 description 8
WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
230000002209 hydrophobic effect Effects 0.000 description 7
239000000203 mixture Substances 0.000 description 7
238000003756 stirring Methods 0.000 description 7
239000004800 polyvinyl chloride Substances 0.000 description 6
229920000915 polyvinyl chloride Polymers 0.000 description 6
238000012360 testing method Methods 0.000 description 6
239000010409 thin film Substances 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical group NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 5
239000007864 aqueous solution Substances 0.000 description 5
150000002632 lipids Chemical class 0.000 description 5
KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 4
HILAYQUKKYWPJW-UHFFFAOYSA-N 1-dodecylguanidine Chemical group CCCCCCCCCCCCN=C(N)N HILAYQUKKYWPJW-UHFFFAOYSA-N 0.000 description 4
108091006629 SLC13A2 Proteins 0.000 description 4
125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 4
230000008901 benefit Effects 0.000 description 4
230000029087 digestion Effects 0.000 description 4
238000012544 monitoring process Methods 0.000 description 4
229920000447 polyanionic polymer Polymers 0.000 description 4
230000008569 process Effects 0.000 description 4
239000002904 solvent Substances 0.000 description 4
238000000807 solvent casting Methods 0.000 description 4
YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
102000053602 DNA Human genes 0.000 description 3
108020004414 DNA Proteins 0.000 description 3
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical class [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
230000002860 competitive effect Effects 0.000 description 3
229920001577 copolymer Polymers 0.000 description 3
239000007799 cork Substances 0.000 description 3
230000003247 decreasing effect Effects 0.000 description 3
239000008151 electrolyte solution Substances 0.000 description 3
239000010408 film Substances 0.000 description 3
125000000524 functional group Chemical group 0.000 description 3
230000000670 limiting effect Effects 0.000 description 3
229920002521 macromolecule Polymers 0.000 description 3
238000005192 partition Methods 0.000 description 3
229920002851 polycationic polymer Polymers 0.000 description 3
229920000642 polymer Polymers 0.000 description 3
239000011591 potassium Chemical class 0.000 description 3
229910052700 potassium Inorganic materials 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
230000002035 prolonged effect Effects 0.000 description 3
229920002477 rna polymer Polymers 0.000 description 3
150000003839 salts Chemical class 0.000 description 3
239000000126 substance Substances 0.000 description 3
UOBBAWATEUXIQF-UHFFFAOYSA-N tetradodecylazanium Chemical group CCCCCCCCCCCC[N+](CCCCCCCCCCCC)(CCCCCCCCCCCC)CCCCCCCCCCCC UOBBAWATEUXIQF-UHFFFAOYSA-N 0.000 description 3
BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 2
229910013594 LiOAc Inorganic materials 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
235000008331 Pinus X rigitaeda Nutrition 0.000 description 2
235000011613 Pinus brutia Nutrition 0.000 description 2
241000018646 Pinus brutia Species 0.000 description 2
230000002411 adverse Effects 0.000 description 2
125000001931 aliphatic group Chemical group 0.000 description 2
238000013459 approach Methods 0.000 description 2
239000008346 aqueous phase Substances 0.000 description 2
125000003118 aryl group Chemical group 0.000 description 2
239000012490 blank solution Substances 0.000 description 2
239000000872 buffer Substances 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
229920001525 carrageenan Polymers 0.000 description 2
235000010418 carrageenan Nutrition 0.000 description 2
230000001143 conditioned effect Effects 0.000 description 2
MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
230000001627 detrimental effect Effects 0.000 description 2
238000011161 development Methods 0.000 description 2
DOIRQSBPFJWKBE-UHFFFAOYSA-N dibutyl phthalate Chemical compound CCCCOC(=O)C1=CC=CC=C1C(=O)OCCCC DOIRQSBPFJWKBE-UHFFFAOYSA-N 0.000 description 2
VICYBMUVWHJEFT-UHFFFAOYSA-N dodecyltrimethylammonium ion Chemical compound CCCCCCCCCCCC[N+](C)(C)C VICYBMUVWHJEFT-UHFFFAOYSA-N 0.000 description 2
238000000835 electrochemical detection Methods 0.000 description 2
238000011049 filling Methods 0.000 description 2
239000004021 humic acid Substances 0.000 description 2
238000010348 incorporation Methods 0.000 description 2
239000002555 ionophore Substances 0.000 description 2
230000000236 ionophoric effect Effects 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
230000007935 neutral effect Effects 0.000 description 2
238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 2
238000011160 research Methods 0.000 description 2
230000000284 resting effect Effects 0.000 description 2
238000001356 surgical procedure Methods 0.000 description 2
238000003786 synthesis reaction Methods 0.000 description 2
238000000954 titration curve Methods 0.000 description 2
239000005968 1-Decanol Substances 0.000 description 1
KGHLIHYTJLWCTP-UHFFFAOYSA-M 2,4-di(nonyl)naphthalene-1-sulfonate;tetradodecylazanium Chemical compound C1=CC=CC2=C(S([O-])(=O)=O)C(CCCCCCCCC)=CC(CCCCCCCCC)=C21.CCCCCCCCCCCC[N+](CCCCCCCCCCCC)(CCCCCCCCCCCC)CCCCCCCCCCCC KGHLIHYTJLWCTP-UHFFFAOYSA-M 0.000 description 1
HCIDWWWVSQJXCM-UHFFFAOYSA-N 2,4-di(nonyl)naphthalene-1-sulfonic acid Chemical compound C1=CC=CC2=C(S(O)(=O)=O)C(CCCCCCCCC)=CC(CCCCCCCCC)=C21 HCIDWWWVSQJXCM-UHFFFAOYSA-N 0.000 description 1
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
HCAPDVCJYXJCAL-UHFFFAOYSA-N 3,7-di(nonyl)naphthalene-1-sulfonic acid Chemical compound C1=C(CCCCCCCCC)C=C(S(O)(=O)=O)C2=CC(CCCCCCCCC)=CC=C21 HCAPDVCJYXJCAL-UHFFFAOYSA-N 0.000 description 1
DPZMVZIQRMVBBW-UHFFFAOYSA-N 5-Phenyl-1-pentanol Chemical compound OCCCCCC1=CC=CC=C1 DPZMVZIQRMVBBW-UHFFFAOYSA-N 0.000 description 1
108091006522 Anion exchangers Proteins 0.000 description 1
239000004475 Arginine Substances 0.000 description 1
241000796533 Arna Species 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical class [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
229920002284 Cellulose triacetate Polymers 0.000 description 1
206010053567 Coagulopathies Diseases 0.000 description 1
MQIUGAXCHLFZKX-UHFFFAOYSA-N Di-n-octyl phthalate Natural products CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC MQIUGAXCHLFZKX-UHFFFAOYSA-N 0.000 description 1
PYGXAGIECVVIOZ-UHFFFAOYSA-N Dibutyl decanedioate Chemical compound CCCCOC(=O)CCCCCCCCC(=O)OCCCC PYGXAGIECVVIOZ-UHFFFAOYSA-N 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
206010020772 Hypertension Diseases 0.000 description 1
239000004472 Lysine Substances 0.000 description 1
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical class [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
239000004677 Nylon Substances 0.000 description 1
229910004727 OSO3H Inorganic materials 0.000 description 1
239000002033 PVDF binder Substances 0.000 description 1
239000004695 Polyether sulfone Substances 0.000 description 1
239000004698 Polyethylene Substances 0.000 description 1
239000004743 Polypropylene Substances 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
208000035965 Postoperative Complications Diseases 0.000 description 1
229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
229910006069 SO3H Inorganic materials 0.000 description 1
GTVWRXDRKAHEAD-UHFFFAOYSA-N Tris(2-ethylhexyl) phosphate Chemical compound CCCCC(CC)COP(=O)(OCC(CC)CCCC)OCC(CC)CCCC GTVWRXDRKAHEAD-UHFFFAOYSA-N 0.000 description 1
NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
239000002253 acid Substances 0.000 description 1
150000007513 acids Chemical class 0.000 description 1
230000009471 action Effects 0.000 description 1
125000000217 alkyl group Chemical group 0.000 description 1
229910000147 aluminium phosphate Inorganic materials 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
239000012491 analyte Substances 0.000 description 1
125000000129 anionic group Chemical group 0.000 description 1
239000003146 anticoagulant agent Substances 0.000 description 1
229940127219 anticoagulant drug Drugs 0.000 description 1
ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
239000013060 biological fluid Substances 0.000 description 1
239000012472 biological sample Substances 0.000 description 1
BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 1
ZFMQKOWCDKKBIF-UHFFFAOYSA-N bis(3,5-difluorophenyl)phosphane Chemical compound FC1=CC(F)=CC(PC=2C=C(F)C=C(F)C=2)=C1 ZFMQKOWCDKKBIF-UHFFFAOYSA-N 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
239000004327 boric acid Substances 0.000 description 1
150000001642 boronic acid derivatives Chemical class 0.000 description 1
239000011575 calcium Chemical class 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
238000004364 calculation method Methods 0.000 description 1
125000004432 carbon atom Chemical group C* 0.000 description 1
238000005266 casting Methods 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
150000003841 chloride salts Chemical class 0.000 description 1
230000035602 clotting Effects 0.000 description 1
230000015271 coagulation Effects 0.000 description 1
238000005345 coagulation Methods 0.000 description 1
238000004891 communication Methods 0.000 description 1
238000007334 copolymerization reaction Methods 0.000 description 1
UZILCZKGXMQEQR-UHFFFAOYSA-N decyl-Benzene Chemical compound CCCCCCCCCCC1=CC=CC=C1 UZILCZKGXMQEQR-UHFFFAOYSA-N 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
230000000994 depressogenic effect Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
238000000502 dialysis Methods 0.000 description 1
MHDVGSVTJDSBDK-UHFFFAOYSA-N dibenzyl ether Chemical compound C=1C=CC=CC=1COCC1=CC=CC=C1 MHDVGSVTJDSBDK-UHFFFAOYSA-N 0.000 description 1
HAKMAMKAFTZXOZ-UHFFFAOYSA-N dioctoxyphosphorylbenzene Chemical compound CCCCCCCCOP(=O)(OCCCCCCCC)C1=CC=CC=C1 HAKMAMKAFTZXOZ-UHFFFAOYSA-N 0.000 description 1
MIMDHDXOBDPUQW-UHFFFAOYSA-N dioctyl decanedioate Chemical compound CCCCCCCCOC(=O)CCCCCCCCC(=O)OCCCCCCCC MIMDHDXOBDPUQW-UHFFFAOYSA-N 0.000 description 1
ITKYCYSYWXAVCC-UHFFFAOYSA-N diundecyl 4-[[3,4-bis(undecoxycarbonyl)phenyl]-hydroxymethyl]benzene-1,2-dicarboxylate Chemical compound C1=C(C(=O)OCCCCCCCCCCC)C(C(=O)OCCCCCCCCCCC)=CC=C1C(O)C1=CC=C(C(=O)OCCCCCCCCCCC)C(C(=O)OCCCCCCCCCCC)=C1 ITKYCYSYWXAVCC-UHFFFAOYSA-N 0.000 description 1
YRIUSKIDOIARQF-UHFFFAOYSA-N dodecyl benzenesulfonate Chemical compound CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1 YRIUSKIDOIARQF-UHFFFAOYSA-N 0.000 description 1
229940071161 dodecylbenzenesulfonate Drugs 0.000 description 1
239000002001 electrolyte material Substances 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
FCQJEPASRCXVCB-UHFFFAOYSA-N flavianic acid Chemical compound C1=C(S(O)(=O)=O)C=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FCQJEPASRCXVCB-UHFFFAOYSA-N 0.000 description 1
238000011990 functional testing Methods 0.000 description 1
239000007789 gas Substances 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
ZRALSGWEFCBTJO-UHFFFAOYSA-O guanidinium Chemical compound NC(N)=[NH2+] ZRALSGWEFCBTJO-UHFFFAOYSA-O 0.000 description 1
125000005843 halogen group Chemical group 0.000 description 1
230000036541 health Effects 0.000 description 1
230000002489 hematologic effect Effects 0.000 description 1
230000000004 hemodynamic effect Effects 0.000 description 1
239000012510 hollow fiber Substances 0.000 description 1
239000012456 homogeneous solution Substances 0.000 description 1
230000003993 interaction Effects 0.000 description 1
238000005184 irreversible process Methods 0.000 description 1
201000002364 leukopenia Diseases 0.000 description 1
231100001022 leukopenia Toxicity 0.000 description 1
238000012417 linear regression Methods 0.000 description 1
150000002634 lipophilic molecules Chemical class 0.000 description 1
239000011777 magnesium Chemical class 0.000 description 1
229910052749 magnesium Chemical class 0.000 description 1
238000013508 migration Methods 0.000 description 1
230000005012 migration Effects 0.000 description 1
238000002156 mixing Methods 0.000 description 1
230000014508 negative regulation of coagulation Effects 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
229920001778 nylon Polymers 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
239000012074 organic phase Substances 0.000 description 1
239000003960 organic solvent Substances 0.000 description 1
230000036284 oxygen consumption Effects 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 1
239000004417 polycarbonate Substances 0.000 description 1
229920000515 polycarbonate Polymers 0.000 description 1
229920006393 polyether sulfone Polymers 0.000 description 1
229920000573 polyethylene Polymers 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
239000004810 polytetrafluoroethylene Substances 0.000 description 1
229920001343 polytetrafluoroethylene Polymers 0.000 description 1
239000004814 polyurethane Substances 0.000 description 1
229920002635 polyurethane Polymers 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
229920002981 polyvinylidene fluoride Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
108090000623 proteins and genes Proteins 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
238000009790 rate-determining step (RDS) Methods 0.000 description 1
230000001172 regenerating effect Effects 0.000 description 1
230000000630 rising effect Effects 0.000 description 1
239000012266 salt solution Substances 0.000 description 1
238000005070 sampling Methods 0.000 description 1
238000000926 separation method Methods 0.000 description 1
230000009919 sequestration Effects 0.000 description 1
229920002379 silicone rubber Polymers 0.000 description 1
239000004945 silicone rubber Substances 0.000 description 1
238000000638 solvent extraction Methods 0.000 description 1
238000002798 spectrophotometry method Methods 0.000 description 1
239000011550 stock solution Substances 0.000 description 1
125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 1
239000003115 supporting electrolyte Substances 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
229920001897 terpolymer Polymers 0.000 description 1
239000012085 test solution Substances 0.000 description 1
238000012956 testing procedure Methods 0.000 description 1
206010043554 thrombocytopenia Diseases 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000001810 trypsinlike Effects 0.000 description 1
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
239000011800 void material Substances 0.000 description 1

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/333—Ion-selective electrodes or membranes
- G01N27/3335—Ion-selective electrodes or membranes the membrane containing at least one organic component
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/49—Blood
- G01N33/492—Determining multiple analytes
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Physics & Mathematics (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Pathology (AREA)
General Health & Medical Sciences (AREA)
General Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Biochemistry (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Chemical Kinetics & Catalysis (AREA)
Food Science & Technology (AREA)
Medicinal Chemistry (AREA)
Biophysics (AREA)
Electrochemistry (AREA)
Microbiology (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Ecology (AREA)
General Chemical & Material Sciences (AREA)
Optics & Photonics (AREA)
Heart & Thoracic Surgery (AREA)
Medical Informatics (AREA)
Surgery (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Investigating Or Analysing Biological Materials (AREA)

CA002617765A 2005-08-05 2006-07-27 Capteurs electrochimiques reversibles de polyions Abandoned CA2617765A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US70611705P	2005-08-05	2005-08-05
US60/706,117		2005-08-05
PCT/US2006/029634 WO2007019097A2 (fr)	2005-08-05	2006-07-27	Capteurs electrochimiques reversibles de polyions

Publications (1)

Publication Number	Publication Date
CA2617765A1 true CA2617765A1 (fr)	2007-02-15

Family

ID=39167262

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002617765A Abandoned CA2617765A1 (fr)	2005-08-05	2006-07-27	Capteurs electrochimiques reversibles de polyions

Country Status (5)

Country	Link
EP (1)	EP1910813A2 (fr)
JP (1)	JP2009503545A (fr)
KR (1)	KR20080053460A (fr)
CN (1)	CN101495838A (fr)
CA (1)	CA2617765A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN114544728A (zh) *	2020-11-25	2022-05-27	中国科学院烟台海岸带研究所	基于脉冲恒电流控制的薄层聚合物膜离子选择性电极及检测方法

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102313767B (zh) *	2010-06-29	2013-09-18	中国科学院烟台海岸带研究所	一种高灵敏聚离子选择性电极及其测试方法
CN102445483B (zh) *	2011-09-30	2014-01-15	中国科学院烟台海岸带研究所	一种肝素的检测方法
CN103808775B (zh) *	2014-03-13	2017-11-03	中国科学院烟台海岸带研究所	一种连续检测肝素的方法及其装置
CN106799196A (zh) *	2015-11-26	2017-06-06	上海美迪维康生物科技有限公司	Dna原位合成半导体芯片及其控制方法
CN108474758B (zh) *	2015-12-18	2021-11-05	雷迪奥米特医学公司	用于改进血液中的尿素检测的混合离子载体离子选择性电极
CN109374720B (zh) *	2018-10-10	2024-01-26	金华职业技术学院	一种电解液中离子浓度测量装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1287345A2 (fr) *	2000-05-18	2003-03-05	Medtronic, Inc.	Electrodes a membrane polymere solide a selectivite ionique
US6872297B2 (en) *	2001-05-31	2005-03-29	Instrumentation Laboratory Company	Analytical instruments, biosensors and methods thereof
KR100926476B1 (ko) *	2003-07-09	2009-11-13	어번 유니버시티	다중이온용 가역형 전기화학 센서

2006
- 2006-07-27 JP JP2008525068A patent/JP2009503545A/ja active Pending
- 2006-07-27 CN CNA200680028701XA patent/CN101495838A/zh active Pending
- 2006-07-27 CA CA002617765A patent/CA2617765A1/fr not_active Abandoned
- 2006-07-27 EP EP06800512A patent/EP1910813A2/fr not_active Withdrawn
- 2006-07-27 KR KR1020087002855A patent/KR20080053460A/ko not_active Withdrawn

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN114544728A (zh) *	2020-11-25	2022-05-27	中国科学院烟台海岸带研究所	基于脉冲恒电流控制的薄层聚合物膜离子选择性电极及检测方法
CN114544728B (zh) *	2020-11-25	2023-10-27	中国科学院烟台海岸带研究所	基于脉冲恒电流控制的薄层聚合物膜离子选择性电极及检测方法

Also Published As

Publication number	Publication date
JP2009503545A (ja)	2009-01-29
EP1910813A2 (fr)	2008-04-16
KR20080053460A (ko)	2008-06-13
CN101495838A (zh)	2009-07-29

Publication	Publication Date	Title
CA2531812C (fr)	2012-12-18	Capteurs electrochimiques reversibles pour polyions
Bakker et al.	2000	Ionophore-based membrane electrodes: new analytical concepts and non-classical response mechanisms
Meyerhoff et al.	1996	Peer reviewed: Polyion-sensitive membrane electrodes for biomedical analysis
Yun et al.	1995	Protamine-sensitive polymer membrane electrode: characterization and bioanalytical applications
JP2003533694A (ja)	2003-11-11	イオン選択的固体状態ポリマー膜電極
US20150177183A1 (en)	2015-06-25	Reversible detection of ions with permselective membranes
JP2006514307A (ja)	2006-04-27	電気化学センサーにおける使用のためのポリマー膜
Ferguson et al.	2018	Advances in electrochemical and optical polyion sensing: A review
CA2617765A1 (fr)	2007-02-15	Capteurs electrochimiques reversibles de polyions
GB2550959A (en)	2017-12-06	Reference electrode with local environment control
US8097135B2 (en)	2012-01-17	Reversible electrochemical sensors for polyions
Fu et al.	1995	Polymer membrane‐based polyion sensors: Development, response mechanism, and bioanalytical applications
WO1991001495A1 (fr)	1991-02-07	Cellule electrochimique, electrode de reference et procede electrochimique
Gemene et al.	2009	Flash chronopotentiometric sensing of the polyions protamine and heparin at ion-selective membranes
Hassan et al.	2002	Determination of carrageenan in food products using potentiometric polyion sensors
EP0833149A1 (fr)	1998-04-01	Procédé pour mesurer la concentration ionique
JPH11230934A (ja)	1999-08-27	サンプル弁別の方法
Chen et al.	2013	Reversible binding and quantification of heparin and chondroitin sulfate in water using redox-stable biferrocenylene SAMs
Mathison et al.	1999	Improving measurement stability and reproducibility of potentiometric sensors for polyions such as heparin
Xu et al.	2008	Reversible detection of proteases and their inhibitors by a pulsed chronopotentiometric polyion-sensitive electrode
Katsu	1998	Determination of the pH difference across a cell membrane using a methylammonium-selective membrane electrode
Wang et al.	2012	Primary-ion-conditioned polymeric membrane electrodes for sensitive detection of polyions
Verpoorte et al.	1992	Calibration of anion permeation in K+ ion-selective electrode membranes using impedance methods
Wang et al.	2023	Self-Calibrated Ion-Selective Electrodes
WO2025102095A1 (fr)	2025-05-22	Électrode de référence pour système de mesure potentiométrique

Legal Events

Date	Code	Title	Description
2012-07-27	FZDE	Discontinued